| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Options Exercise | $2,610 | +100 | +0.01% | $26.10 | 668,045 | 07 Mar 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $13,633 | -100 | -0.01% | $136.33 | 667,945 | 07 Mar 2022 | Direct | F1, F2 |
| transaction | SGEN | Common Stock | Options Exercise | $101,790 | +3,900 | +0.58% | $26.10 | 671,845 | 07 Mar 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $517,608 | -3,900 | -0.58% | $132.72 | 667,945 | 07 Mar 2022 | Direct | F1, F2, F3 |
| transaction | SGEN | Common Stock | Options Exercise | $62,640 | +2,400 | +0.36% | $26.10 | 670,345 | 07 Mar 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $320,856 | -2,400 | -0.36% | $133.69 | 667,945 | 07 Mar 2022 | Direct | F1, F2, F4 |
| transaction | SGEN | Common Stock | Options Exercise | $173,382 | +6,643 | +0.99% | $26.10 | 674,588 | 07 Mar 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $895,078 | -6,643 | -0.98% | $134.74 | 667,945 | 07 Mar 2022 | Direct | F1, F2, F5 |
| transaction | SGEN | Common Stock | Options Exercise | $104,400 | +4,000 | +0.6% | $26.10 | 671,945 | 07 Mar 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $542,480 | -4,000 | -0.6% | $135.62 | 667,945 | 07 Mar 2022 | Direct | F1, F2, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -100 | -0.1% | $0.000000 | 102,158 | 07 Mar 2022 | Common Stock | 100 | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -3,900 | -3.8% | $0.000000 | 98,258 | 07 Mar 2022 | Common Stock | 3,900 | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -2,400 | -2.4% | $0.000000 | 95,858 | 07 Mar 2022 | Common Stock | 2,400 | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -6,643 | -6.9% | $0.000000 | 89,215 | 07 Mar 2022 | Common Stock | 6,643 | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -4,000 | -4.5% | $0.000000 | 85,215 | 07 Mar 2022 | Common Stock | 4,000 | $26.10 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $132.15 to $133.14. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F4 | Reflects sales of common stock executed in multiple transactions at prices ranging from $133.16 to $134.09. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F5 | Reflects sales of common stock executed in multiple transactions at prices ranging from $134.26 to $135.25. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F6 | Reflects sales of common stock executed in multiple transactions at prices ranging from $135.28 to $136.25. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F7 | Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16. |